Cir-ITCH plays an inhibitory role in colorectal cancer by regulating the Wnt/β-Catenin Pathway

288Citations
Citations of this article
79Readers
Mendeley users who have this article in their library.

Abstract

Noncoding RNAs (ncRNAs) are the dominant product of eukaryotic transcription. These products range from short microRNAs (miRNAs) to long intergenic noncoding RNAs (lincRNAs). Circular RNAs composed of exonic sequences represent an understudied form of ncRNA that was discovered more than 20 years ago. Using a TaqMan-based reverse transcriptase polymerase chain reaction assay, we analyzed the relationship between cir-ITCH expression and colorectal cancer (CRC) in a total of 45 CRCs and paired adjacent nontumor tissue samples. We found that cir-ITCH expression was typically down-regulated in CRC compared to the peritumoral tissue. This result, as well as several follow-up experiments, showed that cir-ITCH could increase the level of ITCH, which is involved in the inhibition of the Wnt/β-catenin pathway. Therefore, our results showed that cir-ITCH plays a role in CRC by regulating the Wnt/â-catenin pathway.

Cite

CITATION STYLE

APA

Huang, G., Zhu, H., Shi, Y., Wu, W., Cai, H., & Chen, X. (2015). Cir-ITCH plays an inhibitory role in colorectal cancer by regulating the Wnt/β-Catenin Pathway. PLoS ONE, 10(6). https://doi.org/10.1371/journal.pone.0131225

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free